Key points*RARS2* gene mutation can result in myoclonic epilepsy, mental subnormality, spasticity, and extrapyramidal features like bradykinesis and dystonia*RARS2* gene--related myoclonic epilepsy is an important differential for causes of progressive myoclonic epilepsyIn all cases of infantile onset myoclonic epilepsy *RARS2* gene mutation should be tested

Pontocerebellar hypoplasia type 6 (PCH6), is an autosomal recessive mitochondrial disease caused by mutations in the *RARS2* gene.[1](#epi412108-bib-0001){ref-type="ref"} The *RARS2* gene encodes mitochondrial arginyl transfer RNA synthetase, an enzyme necessary for mitochondrial protein translation.[2](#epi412108-bib-0002){ref-type="ref"} PCH6 is typically characterized by pontine atrophy, vermian hypoplasia, infantile encephalopathy, generalized hypotonia, and intractable seizures.[3](#epi412108-bib-0003){ref-type="ref"} Herein we describe 2 siblings with novel homozygous missense mutations of the *RARS2* gene that presented with myoclonic epilepsy, mental sub‐normality, oculomotor apraxia, spasticity, and dystonia without pontine or vermian hypoplasia.

Methods {#epi412108-sec-0002}
=======

Both siblings were born of a second‐degree consanguineous marriage (Figure [1](#epi412108-fig-0001){ref-type="fig"}). A detailed history was obtained and a routine physical examination was conducted. Extensive clinical and biochemical workup was performed, including tandem mass spectroscopy (TMS), and serum lactate and ammonia tests. Spasticity was graded using the modified Ashworth scale. Brain magnetic resonance imaging (MRI) and electroencephalography (EEG) were also performed. Next‐generation sequencing was carried out for genetic analysis. The complete list of clinical features of both siblings is summarized in Table [1](#epi412108-tbl-0001){ref-type="table-wrap"}.

![Pedigree chart of the family showing the affected siblings and unaffected parents in a second‐degree consanguineous marriage](EPI4-3-270-g001){#epi412108-fig-0001}

###### 

Clinical features exhibited by the 2 siblings

                               Sibling 1                                                 Sibling **2**
  ---------------------------- --------------------------------------------------------- ------------------------------------
  Age/sex                      24 year/Male                                              20 year/Female
  Birth                        Delayed cry                                               Uneventful
  Myoclonus                    Since birth                                               Since birth
  Truncal and appendicular     Truncal and appendicular                                  
  Action and sound sensitive   Action myoclonus                                          
  Improved with drugs          Poor response                                             
  Falls due to jerks           No falls                                                  
  Delayed milestones           Present                                                   Present
  Febrile seizures             Present                                                   Present
  Subnormal Intelligence       Severe                                                    Moderate
  Activities of daily living   Dependent                                                 Independent
  Oculomotor apraxia           Present                                                   Absent
  Spasticity                   Present                                                   Present
  Ashworth score               2                                                         2
  Spastic dysarthria           Present                                                   Present
  Dystonia                     Bradykinesia/dystonia                                     Mild
  Tremors                      Postural                                                  Postural ‐ mild
  Gait                         Spastic                                                   Spastic
  Medications                  Valproate, topiramate                                     Valproate, lamotrigine, zonisamide
  Fundus                       No optic atrophy, retinitis pigmentosa, cherry red spot   
  Hearing                      Normal                                                    
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Genetics {#epi412108-sec-0003}
--------

### Whole‐exome sequencing {#epi412108-sec-0004}

DNA from the proband (Patient 1) was extracted from blood using standard protocol. Sequencing was performed on Illumina HiSeq 2500 using 100x2 V4 kit chemistry with an average sequencing depth of about 100X. Human reference genome GRCh37 was used for alignment. Genome Analysis Tool Kit was used for variant calling. International Haplotype Map Project, 1000 Genomes Project, Online Mendelian Inheritance in Man, data base for non synonymous single‐nucleotide polymorphisms functional prediction, Polymorphism Phenotyping, Catalogue Of Somatic Mutations In Cancer, and Clinically important Variants database were used for variant filtration and annotation. Further classification, annotation, and clinical interpretation was carried out using InterpretOmics database developed by manually curating clinical grade variant information from PubMed and other published data sources.

### Sanger sequencing {#epi412108-sec-0005}

High‐quality DNA was extracted from the blood of the proband, her sibling, and parents using standard protocol. Primers were designed for the identified variant. DNA was then subjected to bidirectional Sanger sequencing to screen the variants in *RARS2* gene using ABI Prism 3730 Genetic Analyzer. Human reference genome GRCh38 was used for alignment.

Results {#epi412108-sec-0006}
=======

Patient 1 {#epi412108-sec-0007}
---------

A 20‐year‐old woman had an uneventful full‐term birth; however, myoclonic jerks were noted immediately after birth. The patient had a history of multiple attacks of simple febrile seizures during childhood. Motor and mental milestones were delayed. The patient currently has mild mental sub‐normality but is independent in activities of daily living.

On physical examination, the patient was found to have spastic dysarthria, postural tremors, bradykinesia, spasticity, and an axial and appendicular myoclonus precipitated by movement and sound (action and audiogenic). Deep tendon reflexes were brisk on both sides with extensor plantar response. MRI of the brain was normal. EEG showed diffused slowing. TMS, and serum lactate and ammonia levels were normal. The patient was treated with valproate, levetiracetam, and topiramate previously, but myoclonic jerks were poorly controlled.

Patient 2 {#epi412108-sec-0008}
---------

A 24‐year‐old man, brother of Patient 1, had myoclonic jerks involving all 4 limbs detected immediately after birth. The patient had a history of multiple attacks of simple febrile seizures during childhood. All developmental milestones were delayed. The patient had severe mental sub‐normality, never attended school, and was dependent in all activities of daily living.

On examination, the patient was found to have oculomotor apraxia, spastic dysarthria, action and audiogenic myoclonus, postural tremors, bradykinesia, dystonia of the limbs, and spasticity in all 4 limbs. Deep tendon reflexes were brisk on both sides with extensor plantar response.

MRI brain was normal. EEG showed diffused slowing. TMS and serum lactate and ammonia levels were normal. The patient was treated with sodium valproate and topiramate, and myoclonic jerks were fairly controlled.

Whole exome sequencing of the proband revealed a homozygous missense variant (c.848T\>A; p.Leu283Gln) in exon 10 of the *RARS2* gene, visualized on an integrated genomic viewer. The variant was noted across all reads of the sequencing run confirming homozygosity (Figure [2](#epi412108-fig-0002){ref-type="fig"}). In silico analysis models (Mutation Taster, Polymorphism Phenotyping v2, and Sorting Intolerant From Tolerant) predict this variant to be pathogenic. This missense variant was not noted previously in the 1000 Genomes Project. Orthogonal validation of the identified variant was performed using Sanger sequencing, and the presence of the variant was confirmed in a homozygous fashion. The unaffected parents and the affected sibling were also noted to have a heterozygous and homozygous copy of the variant, respectively, thus establishing a disease‐variant segregation in the current family (Figure [3](#epi412108-fig-0003){ref-type="fig"}).

![Presence of *RARS2* mutation is seen across all reads of sequencing in an Integrated Genome Viewer](EPI4-3-270-g002){#epi412108-fig-0002}

![Representative image of electropherograms obtained on Sanger evaluation. 3A depicts a homozygous *(T\>*A) variant in the *RARS2* gene noted both in the proband and the affected sibling. 3B depicts the heterozygous form of the same variant that was identified in both parents](EPI4-3-270-g003){#epi412108-fig-0003}

Discussion {#epi412108-sec-0009}
==========

*RARS2* mutations were first described in 2007 in a Jewish family with severe infantile encephalopathy.[4](#epi412108-bib-0004){ref-type="ref"} Typically, mutations of *RARS2* are characterized by neonatal lactic acidosis, intractable seizures, encephalopathy, hypotonia, spasticity, microcephaly, and profound developmental delay.[3](#epi412108-bib-0003){ref-type="ref"} Patients were found to have compound heterozygous mutations in a majority of the reported cases, whereas homozygous mutations have been reported in only 3 other families, apart from this case report.[4](#epi412108-bib-0004){ref-type="ref"}, [5](#epi412108-bib-0005){ref-type="ref"}, [6](#epi412108-bib-0006){ref-type="ref"} This missense variant has been reported previously in a compound heterozygous fashion in association with a 3 base‐pair deletion in siblings affected with PCH6.[7](#epi412108-bib-0007){ref-type="ref"}

To the best of our knowledge, there have been 29 cases of PCH6 reported from 15 families.[1](#epi412108-bib-0001){ref-type="ref"} Compared to patients with classical PCH6, our patients had a milder phenotype and survived well into adulthood. Furthermore, no abnormalities such as pontine or vermian hypoplasia were detected through neuroimaging. Action and audiogenic myoclonus, postural tremors, oculomotor apraxia, spasticity, and dystonia were atypical features in these patients that have not been previously reported in PCH6. The association of myoclonic epilepsy with a *RARS2* mutation is novel and has not been reported previously. The features of RARS2‐associated myoclonic epilepsy and other progressive myoclonic epilepsies have been compared in Table [2](#epi412108-tbl-0002){ref-type="table-wrap"}. Infantile onset may be an important clue to the diagnosis of RARS2‐associated myoclonic epilepsy.

###### 

Comparison of myoclonic epilepsy due to *RARS2* mutation with other progressive myoclonic epilepsies[8](#epi412108-bib-0008){ref-type="ref"}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                              Age of onset (Vein)   Inheritance     Prominent seizures                               Cerebellar signs         Dementia                                       Fundus                                    Dysmorphism   EEG                                                                   MRI                                         Other features
  ------------------------------------------- --------------------- --------------- ------------------------------------------------ ------------------------ ---------------------------------------------- ----------------------------------------- ------------- --------------------------------------------------------------------- ------------------------------------------- -----------------------------------------------------------------------------
  RARS2                                       Birth                 AR              MyoclonusFebrile seizures                        --                       Mental retardation                             Normal                                    No            Diffuse slowing                                                       Normal                                      Oculomotor apraxia, EPS, spasticity and mental retardation

  Unverricht‐Lundborg disease                 6--15                 AR              Stimulus‐sensitive myoclonus\                    Mid and late             Mild and late/absent                           Normal                                    No            Generalized spike‐wave, poly‐spike discharges with photosensitivity   Normal                                      Most common PME
                                                                                    GTCS                                                                                                                                                                                                                                                                                               

  Lafora disease                              12--17                AR              Stimulus sensitive myoclonusOccipital seizures   Early                    Early and relentless                           Normal                                    No            Disorganized with generalized high‐voltage spike‐wave discharges      Diffuse cortical atrophy                    Early emotional disturbance death within 10 years of onset

  Myoclonic epilepsy with ragged red fibers   Any age               Mitochondrial   Myoclonus                                        Variable                 Variable                                       Optic atrophy/ retinopathy +/−            +/−           Generalized spike wave discharges at 2‐5 Hz                           Atrophy with basal ganglion calcification   Ragged red fibers in muscle biopsy, neuropathy, hearing lots

  Neuronal ceroid Lipofuscinosis              Variable              AR/AD           Variable                                         Variable                 Rapidly progressive                            Macular degeneration and visual failure   No            Background disorganization with generalized epileptiform discharges   Atrophy                                     5 types, psychosis, hallucinations. early death and visual loss may be seen

  Sialidosis                                  Variable              AR              Intention and action myoclonus                   Second or third decade   Type I‐absent Type II -- learning difficulty   Cherry red spot                           Type II ++    Low‐voltage fast activity                                             Atrophy in late stages                      Hepatosplenomegaly, recurrent respiratory infections
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AD, autosomal dominant; AR, autosomal recessive.
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Conclusion {#epi412108-sec-0010}
==========

This case report expands on the clinical spectrum of *RARS2* mutations to include myoclonic epilepsy, spasticity, bradykinesia, dystonia, and oculomotor apraxia, in addition to the classical features. In patients of myoclonic epilepsy with atypical features, clinicians should test for *RARS2* mutations.
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